N.M. Heney - Concepedia

Concepedia

Author

N.M. Heney

Massachusetts General Hospital

Also Known As

N M Heney, N. M. HENEY, N.M. HENEY, N.M. Heney, Naill M Heney

18

Publications

1.1K

Citations

10

H-Index

12

Concepts

All Affiliations

Massachusetts General Hospital RTOG Foundation

NH

About

N.M. Heney is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	244
2	Radiation Medicine	3	3	224
3	Radiation Therapy	3	3	234
4	Surgical Oncology	2	2	30
5	Cancer Therapeutics	2	2	22

N.M. Heney

×

9

Publications

1.1K

Citations

9

H-Index

	Year	Citations
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. William U. Shipley, Kathryn Winter, Donald S. Kaufman, Journal of Clinical Oncology	1998	484
Bladder preservation by combined modality therapy for invasive bladder cancer. Lisa A. Kachnic, Donald S. Kaufman, N.M. Heney, Journal of Clinical Oncology	1997	226
RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy Michael P. Hagan, Kathryn Winter, Donald S. Kaufman, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineUrologyRadiation TherapyAccelerated IrradiationMedicine	2003	202
A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER Anthony L. Zietman, William U. Shipley, Donald S. Kaufman, The Journal of Urology	1998	82
Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient. Lisa A. Kachnic, William U. Shipley, Pamela P. Griffin, PubMed	2006	22
Can chemo-radiotherapy plus transurethral tumor resection make cystectomy unnecessary for invasive bladder cancer? William U. Shipley, Donald S. Kaufman, N.M. Heney PubMed Surgical OncologyUrologyUrologic Cancer EpidemiologyRadiation TherapyGenitourinary Cancer	1990	20
Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer. Robert M. Douglas, Donald S. Kaufman, Anthony L. Zietman, PubMed	1996	19
1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA M.K. Tibbs, A.L. Zietmant, K.C. Dallow, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineUrologyT1–2 Prostate CarcinomaRadiation TherapyGenitourinary Cancer	1995	12
41 : A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy William U. Shipley, Kathryn Winter, R. Lee, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation MedicineUrologySelective Bladder PreservationGenitourinary Cancer	1997	10

Page 1